Alkermes plc. Noncash or Part Noncash Acquisition, Investments Acquired
Alkermes plc. (ALKS) reported Noncash or Part Noncash Acquisition, Investments Acquired of $1.16 million for the 9-month period ending 2013-12-31, per its 10-K filed 2015-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 · last filed 2015-02-24
- Alkermes plc. noncash or part noncash acquisition, investments acquired for fiscal 2013 was $1.12M, a 27.86% decline from fiscal 2012.
- Alkermes plc. noncash or part noncash acquisition, investments acquired for fiscal 2012 was $1.55M, a 17.20% increase from fiscal 2011.
- Alkermes plc. noncash or part noncash acquisition, investments acquired for fiscal 2011 was $1.32M.
| Period end | Noncash or Part Noncash Acquisition, Investments Acquired 9 month | Noncash or Part Noncash Acquisition, Investments Acquired 12 month |
|---|---|---|
| 2013-12-31 | $1.16M 10-K · filed 2015-02-24 | |
| 2013-03-31 | $1.12M 10-K · filed 2013-05-23 | |
| 2012-03-31 | $1.55M 10-KT · filed 2014-02-27 | |
| 2011-03-31 | $1.32M 10-K · filed 2013-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |